BlazedX Pharmacogenomics Assays

Fast, Reliable Germline Mutation Detection with qPCR

Pharmacogenomics is reshaping the way therapies are prescribed—connecting inherited genetic differences to how individuals metabolize and respond to common medications. BlazedX PGx panels offer rapid, cost-effective detection of key germline variants using standard qPCR instrumentation.

Built for Speed

Designed for versatility and speed, BlazedX PGx panels allow labs to deliver high-impact results without the need for complex NGS workflows. These assays require minimal DNA input and run on widely available 4-channel qPCR platforms, making them an ideal fit for labs expanding their molecular capabilities.

Why Choose BlazedX PGX Assays

Empowering Precision Without Complexity

BlazedX PGx assays deliver essential pharmacogenomic insights without the delays and cost of sequencing. Laboratories can now offer actionable results that are both safer and more effective—quickly and reliably.

Explore PGx Panels

The PGx Assay 4 is designed for in vitro assessment of DIO2 variants using real-time PCR.
The PGx Assay 3 is designed for in vitro assessment of CYP3A5 using real-time PCR.
The PGx Assay 2 is designed for in vitro assessment of ACE using real-time PCR.
The PGx Assay 1 is designed for in vitro assessment of SLCO1B1 variants using real-time PCR.

Assay Highlights

ParameterSpecification
Input DNA1 ng (magnetic bead extraction)
Detection ChannelsFAM, HEX
Reaction Volume10 µl
Kit Sizes48 or 200 samples
Platform4-channel qPCR, Bio-Rad, ABI